Literature DB >> 24571868

15-deoxy-Δ¹²,¹⁴-prostaglandin J₂ ameliorates endotoxin-induced acute lung injury in rats.

Dong Liu1, Zhilong Geng2, Wankun Zhu3, Huiwen Wang2, Ye Chen2, Juan Liang4.   

Abstract

BACKGROUND: A proinflammatory milieu emerging in the lung due to neutrophil accumulation and activation is a key in the pathogenesis of acute lung injury (ALI). 15-deoxy-Δ(12, 14)-prostaglandin J2 (15d-PGJ2), one of the terminal products of the cyclooxygenase-2 pathway, is known to be the endogenous ligand of peroxisome proliferator-activated receptor γ (PPAR-γ) with multiple physiological properties. Growing evidence indicates that 15d-PGJ2 has anti-inflammatory, antiproliferative, cytoprotective and pro-resolving effects. We investigated whether 15d-PGJ2 has a protective effect against endotoxin-induced acute lung injury in rats.
METHODS: Twenty-four male Wistar rats were randomly assigned into four groups (n = 6 per group): sham+vehicle group, sham+15d-PGJ2 group, LPS+vehicle group, and LPS+15d-PGJ2 group. The rats were given either lipopolysaccharide (LPS, 6 mg/kg intravenously) or saline, and pretreated with 15d-PGJ2 (0.3 mg/kg intravenously) or its vehicle (dimethyl sulphoxide) 30 minutes before LPS. Histological alterations, wet/dry weight (W/D) ratio and myeloperoxidase (MPO) activity as well as tumor necrosis factor (TNF)-α and cytokine-induced neutrophil chemoattractant-1 (CINC-1) levels were determined in lung tissues four hours after LPS injection. Immunohistochemical analysis for intercellular adhesion molecule-1 (ICAM-1) expression and Western blotting analysis for nuclear factor (NF)-κB p65 translocation and IκBα protein levels were also studied.
RESULTS: 15d-PGJ2 pretreatment significantly attenuated LPS-induced lung injury, and reduced the increased W/D ratio, MPO activity, TNF-α, CINC-1 levels, and ICAM-1 expression in the lung. 15d-PGJ2 also suppressed the nuclear NF-κB p65 translocation and increased cytosolic IκBα levels.
CONCLUSIONS: 15d-PGJ2 protects against endotoxin-induced acute lung injury, most likely through the reduction of proinflammatory protein levels during endotoxemia subsequent to the inhibition of NF-κB activation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24571868

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  6 in total

1.  Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis.

Authors:  Yun-Fang Zhang; Xun-Liang Zou; Jun Wu; Xue-Qing Yu; Xiao Yang
Journal:  Inflammation       Date:  2015-12       Impact factor: 4.092

Review 2.  PPARγ and the Innate Immune System Mediate the Resolution of Inflammation.

Authors:  Amanda Croasdell; Parker F Duffney; Nina Kim; Shannon H Lacy; Patricia J Sime; Richard P Phipps
Journal:  PPAR Res       Date:  2015-12-02       Impact factor: 4.964

3.  Activation of c-Src tyrosine kinase mediated the degradation of occludin in ventilator-induced lung injury.

Authors:  Tao Zhao; Mengjie Liu; Changping Gu; Xin Wang; Yuelan Wang
Journal:  Respir Res       Date:  2014-12-04

Review 4.  PPARγ in Bacterial Infections: A Friend or Foe?

Authors:  Aravind T Reddy; Sowmya P Lakshmi; Raju C Reddy
Journal:  PPAR Res       Date:  2016-09-28       Impact factor: 4.964

5.  Effect of 15-Deoxy-Δ12,14-prostaglandin J2Nanocapsules on Inflammation and Bone Regeneration in a Rat Bone Defect Model.

Authors:  Qi Tang; Li-Li Chen; Fen Wei; Wei-Lian Sun; Li-Hong Lei; Pei-Hui Ding; Jing-Yi Tan; Xiao-Tao Chen; Yan-Min Wu
Journal:  Chin Med J (Engl)       Date:  2017-02-05       Impact factor: 2.628

6.  Role of glutamine in the mediation of E-cadherin, p120-catenin and inflammation in ventilator-induced lung injury.

Authors:  Jian-Lei Qiu; Bai-Ling Song; Yu-Juan Wang; Fu-Tao Zhang; Yue-Lan Wang
Journal:  Chin Med J (Engl)       Date:  2018-04-05       Impact factor: 2.628

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.